Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR…
Biotechnology
US, Cambridge [HQ]
Insiders
Transactions
Track non-derivative insider transactions.
i = Indirect Ownership
d = Direct Ownership
cs = Common Stock
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra |
---|
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: